Viewpoint
04.08.22
Closing the U.S. to Chinese Biotech Would Do Far More Harm Than Good
Biotechnology intrinsically blurs boundaries between science and commerce, market and state, the global and the national, and even personal privacy and collective interest. Progress depends more heavily in biotech than in other high-tech industries...
Viewpoint
03.18.20
‘This Is Not Forensic Genetics Anymore. This Is Surveillance.’
Yves Moreau, a professor specializing in human clinical genomics, had been emailing with Promega since 2016, warning its communications department first about how Promega’s products might be used in a proposed DNA databasing project in Kuwait, and...
Features
02.19.20
American Company Sold DNA Analysis Equipment to Security Officials in Xinjiang, Documents Show
In 2015, the Xinjiang Production and Construction Corps Public Security Bureau announced it planned to purchase equipment from the U.S.-based biotechnology company Promega for the purpose of analyzing DNA and adding it to a national database,...
ChinaFile Recommends
01.24.18US-China Biotech Startup XtalPi Lands $15m from Google, Tencent and Sequoia
TechCrunch
Google continues to increase its presence in China after it joined Sequoia China and Tencent in a $15 million investment for XtalPi, a U.S.-China biotech firm that uses artificial intelligence and computing to accelerate the development of new drugs.
ChinaFile Recommends
09.20.17China Rushes to Surpass U.S. In Decoding Citizens' Genes
Wall Street Journal
In this western Chinese city famed for panda conservation, scientists are advancing the world’s most ambitious effort to save a far less-endangered species: humans.